OS Therapies
PublicOS Therapies is now publicly traded
The data on this page reflects OS Therapies's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Convertible Debt
Jul 16, 2026
Total Funding Raised
$3.6M
Company Overview
OS Therapies is a clinical-stage biopharmaceutical company that focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors.
AI Layer
Non-AI
Keywords
OS Therapies Comparables
Compare OS Therapies with similar companies based on industry and business-model similarity.
No public comparables are available for OS Therapies. Request access to learn about comparables coverage.
Request accessOS Therapies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | Jul 16, 2026 | ||||
| Seed Round | Mar 6, 2026 |
Key People
Founding team and executive leadership
OS Therapies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access